etrasimod

Etrasimod (1206123-37-6) Etrasimod is a novel oral, selective sphingosine 1-phosphate (S1P) receptor modulator indicated for the treatment of adult patients with moderately to severely active ulcerative colitis. It functions by partially and reversibly blocking lymphocyte outflow, reducing peripheral blood lymphocyte counts, thereby limiting lymphocyte migration to the intestines and delivering therapeutic benefits. Product Specifications Product Name: Etrasimod CAS No.:

4-ChloroMethyl-1-cyclopentyl-2-trifluoroMethyl-benzene (957208-65-0) 4-ChloroMethyl-1-cyclopentyl-2-trifluoroMethyl-benzene is a key chemical intermediate used in the synthesis of Etrasimod. Product Name 4-ChloroMethyl-1-cyclopentyl-2-trifluoroMethyl-benzene CAS No. 957208-65-0 Assay 98% End Use Etrasimod Molecular Formula C13 H14 ClF3 Molecular Weight 262.7 Shelf Life 2 Years Package 25kg/drum

Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate (1206124-13-1) Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate is a key pharmaceutical intermediate used in the synthesis of Etrasimod. Product Specifications Product Name: Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate CAS No.: 1206124-13-1 Assay: 98% End Use: Etrasimod Intermediate Molecular Formula: C15 H17 NO3 Molecular Weight: 259.3 Shelf Life: 2 Years Package: